Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing two methods of ondansetron administration for pain relief after weight loss surgery

Official title: Intravenous Versus Perineural Ondansetron as an Adjuvant in Autonomic Neural Blockade for Laparoscopic Sleeve Gastrectomy: A Two-Center, Randomized, Double-Blind, Non-inferiority Trial

Run by Tanta University · NCT06810882 · Data updated 2026-11-12

This study is testing whether giving ondansetron through a nerve block can help reduce pain and nausea after weight loss surgery just as well as the traditional intravenous method.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment482 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, Gharbia Governorate)
StatusRecruiting
StartedFebruary 16, 2025
Main results expectedFebruary 16, 2027
Study endsFebruary 17, 2027
Registry record updatedMay 15, 2026
Trial IDNCT06810882 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-65 with a BMI over 35 and associated comorbidities, scheduled for laparoscopic sleeve gastrectomy.

Probably not a fit

Patients with allergies to the study drugs, chronic pain disorders, or those with a history of gastrointestinal surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective randomized non-inferiority study aims to evaluate the analgesic and anti-emetic effects of intravenous ondansetron versus perineural ondansetron in patients undergoing laparoscopic sleeve gastrectomy. The study focuses on addressing postoperative pain and nausea, which are common complications following bariatric surgery. By utilizing a novel approach called paragastric autonomic neural blockade, the researchers will assess the effectiveness of these two methods in managing symptoms post-surgery. The goal is to determine if perineural administration provides similar or superior benefits compared to the traditional intravenous route.

Why it matters

Potential benefit: If successful, this study could enhance postoperative care by reducing pain and nausea in patients undergoing weight loss surgery.

How similar studies have gone: Previous studies have shown promising results with similar approaches, indicating potential for effective pain and nausea management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients of either sex
* American Society Anesthesiologists physical (ASA) status II-III
* age between 18-65 years old
* Body mass index (BMI) \>35 kg/m2 with comorbidity or \> 40 kg/m2 -- undergoing laparoscopic sleeve gastrectomy with intraoperative surgeon performed laparoscopic paragastric autonomic neural blockade..

Exclusion Criteria:

* Allergy to experimental drugs.
* Known to have long QT, previous history of postoperative nausea and vomiting
* Abuse of alcohol, analgesia, or sedative antidepressant drugs
* Chronic pain disorders
* History of previous upper gastrointestinal system surgery, those with surgery-related complications during or after surgery.
* Liver or kidney failure
* Performance of concomitant procedures in addition to laparoscopic sleeve gastrectomy
* Anesthetic complications that may alter the postoperative management protocol.

Where it's running

  • Tanta University Hospitals
    Tanta, Gharbia Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.